Bone mineral density and serum levels of soluble tumor necrosis factors, estradiol, and osteoprotegerin in postmenopausal women with cirrhosis after viral hepatitis

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 4844-4850

  González Calvin, Jorge L ^a   Mundi, Jose L ^a   Casado Caballero, Francisco J ^a   Abadia, Ana C ^a,b   Martin Ibañez, Jose J ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; ESTRADIOL; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; COMMUNITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DESCRIPTIVE RESEARCH; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; LIVER CIRRHOSIS; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; VIRUS HEPATITIS;

EID: 73249125667     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0835     Document Type: Article

References (39)

1. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S 1990 Osteoporosis and skeletal fractures in chronic liver disease. Gut 31:82-87
2. Gallego-Rojo FJ, Gonzalez-Calvin JL, Muñoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D 1998 Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 28:695-699
3. Gonzalez-Calvin JL, Gallego-Rojo F, Fernandez-Perez R, Casado-Caballero F, Ruiz-Escolano E, Olivares EG 2004 Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis. J Clin Endocrinol Metab 89:4325-4330
4. Leslie WD, Bernstein CN, Leboff MS 2003 American Gastroenterological Association Clinical Practice Committee. AGA technical review on osteoporosis in hepatic disorders. Gastroenterology 125:941-966
5. Bagur A, Mautalen C, Findor J, Sorda J, Somoza J 1998 Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385-390
6. Shiomi S, Kuroki T, Masaki K, Takeda T, Nishiguchi S, Nakajima S, Seki S, Kobayashi K, Okamura T, Ochi H 1994 Osteopenia in primary biliary cirrhosis and cirrhosis of the liver in women, evaluated by dualenergy x-ray absorptiometry. J Gastroenterol 29:605-609
7. Crawford BA, Kam C, Donaghy AJ, McCaughan GW 2003 The heterogeneity of bone disease in cirrhosis: a multivariate analysis. Osteoporos Int 14:987-994
8. Collier JD, Ninkovic M, Compston JE 2002 Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50:i1-i9
9. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI 1991 Circulating tumor necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 13:267-276
10. Diez Ruiz A, Santos Perez JL, Lopez Martinez G, Gonzalez Calvín J, Gil Extremera B, Gutierrez Gea F 1993 Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis. Alcohol Alcohol 28:319-323
11. Gonzalez-Calvin JL, Tilz GP, Gallego-Rojo F, Torres-Almendros M, Widner B, Diez-Ruiz A, Rico-Irles J, Fuchs D 2000 Neopterin, soluble receptors for interleukin-2 and tumor necrosis factor in viral cirrhosis and alcoholic cirrhosis. Pteridines 11:43-47
12. Pacifici R 1996 Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11:1043-1051
13. Hofbauer LC, Lacey DL, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S 1999 Interleukin-1β and tumor necrosis factor-α, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone 25:255-259
14. Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL 2000 TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481-1488
15. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF 1996 Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nat Med 2:1132-1136
16. Shevde NK, Bendixen AC, Dienger KM, Pike JW 2000 Estrogens suppressRANKligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7829-7834
17. Srivastava S, Toraldo G, Weitzmann MN, Cenci S, Ross FP, Pacifici R2001 Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-κB ligand (RANKL)-induced JNK activation. J Biol Chem 276:8836-8840
18. Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle WJ, Lacey DL, Riggs BL 2003 Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest 111:1221-1230
19. Malyankar UM, Scatena M, Suchland KL, Yun TJ, Clark EA, Giachelli CM 2000 Osteoprotegerin is an αvβ3-induced, NF-κB-dependent survival factor for endothelial cells. J Biol Chem 275:20959-20962
20. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Spelsberg TC, Riggs BL 1999 Estrogen stimulates gene expression and protein production of osteoprotegerin in human osteoblastic cells. Endocrinology 140:4367-4370
21. Becker U, Gluud C, Farholt S, Bennett P, Micic S, Svenstrup B, Hardt F 1991 Menopausal age and sex hormones in postmenopausal women with alcoholic and non-alcoholic liver disease. J Hepatol 13:25-32
22. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R 1973 Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-649
23. Rinaldi S, Dechaud H, Biessy C 2001 Reliability and validity of commercially available, direct radioimmunoassay for measurements of blood androgens and estrogens in postmenopausal women. Cancer Epidemiol Biomark Prev 10:757-765
24. Jódar E, Muñoz-Torres M, Escobar-Jiménez F, Quesada M, Luna JD, Olea N 1997 Antiresorptive therapy in hyperthyroid patients: longitudinal changes in bone and mineral metabolism. J Clin Endocrinol Metab 82:1989-1994
25. Diaz Curiel M,Carrasco de la Peña JL, Honorato Perez J, Perez Cano R, Rapado A, Ruiz Martinez I 1997 Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre Research Project on Osteoporosis. Osteoporos Int 7:59-64
26. WHO Study Group 1994 Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Tech Rep Ser 843. Geneva: World Health Organization
27. Mezquita-Raya P, de la Higuera M, García DF, Alonso G, Ruiz-Requena ME, de Dios Luna J, Escobar-Jiménez F, Muñoz-Torres M 2005 The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Osteoporos Int 16:1368-1374
28. Vestergaard P, Rejnmark L, Mosekilde L 2005 Osteoporosis is markedly underdiagnosed: a nationwide study from Denmark. Osteoporos Int 16:134-141
29. Gonzalez-Calvín JL, Garcia-Sanchez A, Bellot V,Muñoz-Torres M, Raya-Alvarez E, Salvatierra-Rios D 1993 Mineral metabolism, osteoblastic function and bone mass in chronic alcoholism. Alcohol Alcohol 28:571-579
30. García-Sanchez A, Gonzalez-Calvin JL, Diez-Ruiz A, Casals JL, Gallego-Rojo F, Salvatierra D 1995 Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function. Alcohol Alcohol 30:449-453
31. Gonzalez-Calvin JL, Garcia-Sanchez A, Mundi JL, Gonzales-Calvin JL 1999 Effect of alcohol consumption on adult bone mineral density and bone turnover markers. Alcohol Clin Exp Res 23:1416-1417
32. Felson DT, Zhang Y, Hannan MT, Kannel WB, Kiel DP 1995 Alcohol intake and bone mineral density in elderly men and women. The Framingham Study. Am J Epidemiol 142:485-492
33. Holbrook TL, Barrett-Connor E 1993 A prospective study of alcohol consumption and bone mineral density. BMJ 306:1506-1509
34. Gavaler JS, Deal SR, Van ThielDH, Arria A, Allan MJ 1993 Alcohol and estrogen levels in postmenopausal women: the spectrum of effect. Alcohol Clin Exp Res 17:786-790
35. Gonzalez-Calvin JL, Mundi JL, Casado FJ, Olivares EG 2004 Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis. Gastroenterology 126:1225-1226; author reply 1226
36. Yano K, Tsuda E, Washida N, Kobayashi F, Goto M, Harada A, Ikeda K, Higashio K, Yamada Y 1999 Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis. J Bone Miner Res 14:518-527
37. Eriksen EF, Brixen K, Charles P 1995 New markers of bone metabolism: clinical use in metabolic bone disease. Eur J Endocrinol 132:251-263
38. Bisballe S, Eriksen EF, Melsen F, Mosekilde L, Sørensen OH, Hessov I 1991 Osteopenia and osteomalacia after gastrectomy: interrelations between biochemical markers of bone remodelling, vitamin D metabolites, and bone histomorphometry. Gut 32:1303-1307
39. Canalis E, Lian JB 1988 Effects of bone associated growth factors on DNA, collagen and osteocalcin synthesis in cultured fetal rat calvariae. Bone 9:243-246